Would you offer radiation therapy to the prostate in addition to up to 1-3 osseous metastases in a patient with newly castrate-resistant oligometastatic prostate cancer, with no prior treatment to the prostate?   

Would you consider this even though this falls out of scope of STAMPEDE trial? Under what circumstances would you consider such an approach versus not?



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Ascension Saint Agnes Cancer Institute
Most of these patients with oligometastatic diseas...
Sign in or Register to read more